TherapeuticsMD Revenue and Competitors
Estimated Revenue & Valuation
- TherapeuticsMD's estimated annual revenue is currently $90.8M per year.
- TherapeuticsMD received $85.0M in venture funding in August 2018.
- TherapeuticsMD's estimated revenue per employee is $307,966
- TherapeuticsMD's total funding is $508.6M.
- TherapeuticsMD's current valuation is $144.5M. (January 2022)
- TherapeuticsMD has 295 Employees.
- TherapeuticsMD grew their employee count by -14% last year.
TherapeuticsMD Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is TherapeuticsMD?
TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. We create products to address the unique changes and challenges women experience through every stage of their lives. With momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. This includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD® brands. See our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelineskeywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
Number of Employees
Employee Growth %
TherapeuticsMD Inc. stock falls Friday, underperforms market MarketWatch
TherapeuticsMD Completes the Divestiture of vitaCare Prescription ... Business Wire
Russell Angus C., Director, added 10,000 shares of TherapeuticsMD, Inc. (TXMD) to its portfolio at the rate of $2.77 per share valuing $27,700 ...
Shares of TherapeuticsMD (NASDAQ: TXMD) jumped 34% in August, according to data provided by S&P Global Market Intelligence, after the ...
TherapeuticsMD Inc. shares TXMD, +3.61% slid about 6% Tuesday, after the Securities and Exchange Commission charged the company with ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|2015-02-12||$Undisclosed||Undisclosed||Cowen and Company||Article|
|2018-08-01||$85.0M||Undisclosed||Goldman Sachs & Co. LLC||Article|